Omeros

is a Wasington-based biopharmaceutical company that researches and develops small-molecule and protein therapeutics for the treatment of inflammation and CNS disorders...
Read more
Omeros Chairman & CEO: Gregory A. Demopulos

Chairman & CEO

Gregory A. Demopulos

CEO Approval Rating

92/100

1994

PublicIndependent CompanyNASDAQOMER

28342836 NAICS listing
Annual Revenue
$97.7M
Employees
210
Funding
$94.9M

Omeros Competitors

1Supernus
2Minerva Neurosciences
3Cognition
4NeuroNano
5Voyager
6Auspex Pharmaceuticals
7Alector
8Cynapsus
9ProMIS Neurosciences
10Verge Genomics
See 14+ competitors

Trending Companies